Engineering Skin with Skinny Genes

Anika Böttcher; Heiko Lickert; Matthias Tschöp

doi:10.1016/j.stem.2017.07.013

Engineering Skin with Skinny Genes

Anika Böttcher
, Heiko Lickert
, Matthias Tschöp

Helmholtz Center Munich

Research output: Contribution to journal › Short survey › peer-review

Abstract

The increasing prevalence of obesity and diabetes is an urgent worldwide health challenge. Now in Cell Stem Cell, Yue et al. (2017) report a proof-of-concept study using genetically engineered skin transplants that produce the incretin GLP-1 to prevent diet-induced obesity, suggesting a powerful approach for treating metabolic disorders.

Original language	English
Pages (from-to)	153-155
Number of pages	3
Journal	Cell Stem Cell
Volume	21
Issue number	2
DOIs	https://doi.org/10.1016/j.stem.2017.07.013
State	Published - 3 Aug 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.stem.2017.07.013

Cite this

@article{2c304ef1d225458e84ee18c19a2e585d,

title = "Engineering Skin with Skinny Genes",

abstract = "The increasing prevalence of obesity and diabetes is an urgent worldwide health challenge. Now in Cell Stem Cell, Yue et al. (2017) report a proof-of-concept study using genetically engineered skin transplants that produce the incretin GLP-1 to prevent diet-induced obesity, suggesting a powerful approach for treating metabolic disorders.",

author = "Anika B{\"o}ttcher and Heiko Lickert and Matthias Tsch{\"o}p",

note = "Publisher Copyright: {\textcopyright} 2017",

year = "2017",

month = aug,

day = "3",

doi = "10.1016/j.stem.2017.07.013",

language = "English",

volume = "21",

pages = "153--155",

journal = "Cell Stem Cell",

issn = "1934-5909",

publisher = "Cell Press",

number = "2",

}

TY - JOUR

T1 - Engineering Skin with Skinny Genes

AU - Böttcher, Anika

AU - Lickert, Heiko

AU - Tschöp, Matthias

PY - 2017/8/3

Y1 - 2017/8/3

N2 - The increasing prevalence of obesity and diabetes is an urgent worldwide health challenge. Now in Cell Stem Cell, Yue et al. (2017) report a proof-of-concept study using genetically engineered skin transplants that produce the incretin GLP-1 to prevent diet-induced obesity, suggesting a powerful approach for treating metabolic disorders.

AB - The increasing prevalence of obesity and diabetes is an urgent worldwide health challenge. Now in Cell Stem Cell, Yue et al. (2017) report a proof-of-concept study using genetically engineered skin transplants that produce the incretin GLP-1 to prevent diet-induced obesity, suggesting a powerful approach for treating metabolic disorders.

UR - https://www.scopus.com/pages/publications/85026504540

U2 - 10.1016/j.stem.2017.07.013

DO - 10.1016/j.stem.2017.07.013

M3 - Short survey

C2 - 28777938

AN - SCOPUS:85026504540

SN - 1934-5909

VL - 21

SP - 153

EP - 155

JO - Cell Stem Cell

JF - Cell Stem Cell

IS - 2

ER -

Engineering Skin with Skinny Genes

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this